Pacira BioSciences faces significant risk as generic challenges threaten Exparel, its flagship product responsible for 78% of 2024 revenue. PCRX's complex formulation, robust patent estate, and ...
President Trump has delayed imposing tariffs on pharmaceuticals to allow for more negotiations with drug companies. (Francis Chung/Bloomberg News) The Trump administration says it doesn't plan to ...
Big pharmaceutical companies are boosting their production capacity of branded medications with billions of dollars in new U.S. manufacturing plant construction, but generic drug production still ...
The U.S. Food and Drug Administration has launched a new pilot program to speed up the review process for generic drugs that are tested and manufactured entirely in the United States, the regulator ...
US Securities and Exchange Commission Chair Paul Atkins says the new listing standards will reduce barriers to access digital asset products and give investors more choice. ”This approval helps to ...
ANDERLECHT, Belgium--(BUSINESS WIRE)--A.forall is pleased to announce the acquisition of four FDA-approved injectable generics and two late-stage pipeline assets from Provepharm's US portfolio. With ...
NEW YORK, Sept 2 (Reuters) - Some Chinese companies now racing to make generic versions of Novo Nordisk's (NOVOb.CO), opens new tab Wegovy also supplied ingredients for more than a billion makeshift ...
Medications are rarely made from start to finish in a single country; raw materials, active ingredients and final products often cross multiple borders before reaching patients in the U.S., The New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback